Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Translational Autoimmunity: Treatment of Autoimmune Diseases Publisher



Rezaei N1, 2, 3
Authors

Source: Translational Autoimmunity: Treatment of Autoimmune Diseases Published:2022


Abstract

Translational Autoimmunity: Treatment of Autoimmune Diseases, Volume Two in the Translational Immunology series, focuses on advances in therapeutic modalities in autoimmune diseases. Efficacy and safety of not only the current biologic therapies, but also novel drug targets are discussed. Therapeutic targeting of B regulatory cells, T regulatory cells, as well as the immunomodulation effects of nanoparticles and organisms are also covered, along with our understanding and future challenges of prognostic significance of treatments in autoimmune diseases. © 2022 Elsevier Inc. All rights reserved.
Related Docs
View other Related Docs
1. Multiple Sclerosis: Therapeutic Applications of Advancing Drug Delivery Systems, Biomedicine and Pharmacotherapy (2017)
2. Biomimetic Nanotechnology for Cancer Immunotherapy: State of the Art and Future Perspective, International Journal of Pharmaceutics (2024)
3. Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5, Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5 (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (7)
Ali Akbar Amirzargar (2)
Other Related Docs
4. Introduction on Translational Autoimmunity: From Bench to Bedside, Translational Autoimmunity: Etiology of Autoimmune Diseases (2021)
5. Introduction on Treatment for Infectious Diseases and Immunological Disorders, Encyclopedia of Infection and Immunity (2022)
6. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-Coated Plga Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis, Iranian Journal of Allergy# Asthma and Immunology (2017)
7. Overview and Recent Advances of Regulatory T Cell Therapy in Solid Organ Transplantation, Iranian Journal of Kidney Diseases (2021)
8. Application of Nanoparticle Technology in the Treatment of Systemic Lupus Erythematous, Biomedicine and Pharmacotherapy (2016)
9. Evaluation of the Immune Checkpoint Factors in Idiopathic Membranous Nephropathy, Molecular and Cellular Probes (2023)
10. B Cell Modulation Strategies in the Improvement of Transplantation Outcomes, Molecular Immunology (2020)
11. Emerging Therapeutic Potential of Regulatory T (Treg) Cells for Rheumatoid Arthritis: New Insights and Challenges, International Immunopharmacology (2022)
12. Towards Personalized Medicine for Patients With Autoimmune Diseases: Opportunities and Challenges, Immunology Letters (2017)
13. Introduction on Challenges for Autoimmune Diseases, Translational Autoimmunity: Challenges for Autoimmune Diseases: Volume 5 (2022)
14. Dysregulated Expression of Mirnas in Immune Thrombocytopenia, Epigenomics (2021)
15. Cell Therapy in Transplantation: A Comprehensive Review of the Current Applications of Cell Therapy in Transplant Patients With the Focus on Tregs, Car Tregs, and Mesenchymal Stem Cells, International Immunopharmacology (2021)
16. Translational Autoimmunity: Etiology of Autoimmune Diseases, Translational Autoimmunity: Etiology of Autoimmune Diseases (2021)
17. Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Ace Card to Address Autoimmune Diseases, International Journal of Stem Cells (2020)
18. The Paths and Challenges of “Off-The-Shelf” Car-T Cell Therapy: An Overview of Clinical Trials, Biomedicine and Pharmacotherapy (2023)
19. Introduction on Therapeutic Opportunities for Autoimmunity, Translational Autoimmunity: Treatment of Autoimmune Diseases (2022)
20. Novel Car T Therapy Is a Ray of Hope in the Treatment of Seriously Ill Aml Patients, Stem Cell Research and Therapy (2021)